Atlas Trials

Grazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic Nephropathy

Clinical trial NCT03433326 · UNKNOWN

Trial details

NCT number
NCT03433326
Sponsor
University of Florence
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatitis CCryoglobulinaemic Glomerulonephritis
Start date
2018-03-01
Primary completion
2018-12-31
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.